Your browser doesn't support javascript.
loading
The path to the clinic: a comprehensive review on direct KRASG12C inhibitors.
Kwan, Albert K; Piazza, Gary A; Keeton, Adam B; Leite, Caio A.
Affiliation
  • Kwan AK; University of South Alabama College of Medicine, Mobile, AL, USA. akk1722@jagmail.southalabama.edu.
  • Piazza GA; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA.
  • Keeton AB; Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA.
  • Leite CA; Hospital BP, Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
J Exp Clin Cancer Res ; 41(1): 27, 2022 Jan 19.
Article in En | MEDLINE | ID: mdl-35045886
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins p21(ras) / Drug Development / Immunotherapy Limits: Humans Language: En Journal: J Exp Clin Cancer Res Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins p21(ras) / Drug Development / Immunotherapy Limits: Humans Language: En Journal: J Exp Clin Cancer Res Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom